Furthermore, the unique PDE5 expression patterns observed in breast cancer tissues and the mounting evidence of the anticancer properties of cGMP signaling warrant further investigation into this signaling pathway as a potential target for future anticancer drug discovery efforts. This evidence concerns the gene PDE5A and breast carcinoma.